Loading…
CVS Health Corporation is projected to rise to $127.73 by 2027, a +39% move from its current price of $92.07. CVS is currently trading above its 50-day average (a bullish sign). Technical indicators currently lean strong buy.
A data-driven summary — not financial advice. See the full breakdown below.
Live market data via Yahoo Finance · updated 5/28/2026
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| May 29 | $90.51 | $92.13 | $93.78 | +0.06% |
| May 30 | $89.90 | $92.19 | $94.53 | +0.13% |
| May 31 | $89.45 | $92.24 | $95.12 | +0.19% |
| Jun 1 | $89.08 | $92.30 | $95.64 | +0.25% |
| Jun 2 | $88.77 | $92.36 | $96.10 | +0.32% |
| Jun 3 | $88.49 | $92.42 | $96.52 | +0.38% |
| Jun 4 | $88.24 | $92.48 | $96.92 | +0.44% |
| Period | Min | Prediction | Max | Change |
|---|---|---|---|---|
| Week 1 | $88.24 | $92.48 | $96.92 | +0.44% |
| Week 2 | $86.92 | $92.88 | $99.26 | +0.88% |
| Week 3 | $86.01 | $93.29 | $101.20 | +1.33% |
| Week 4 | $85.31 | $93.71 | $102.93 | +1.78% |
| Week 5 | $84.74 | $94.12 | $104.53 | +2.23% |
| Week 6 | $84.27 | $94.54 | $106.05 | +2.68% |
| Week 7 | $83.87 | $94.95 | $107.51 | +3.13% |
Short-term targets derived from the forecast trend and recent volatility. Highly uncertain — not financial advice.
CVS Health Corporation provides health solutions in the United States. The company operates through Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness segments. The Health Care Benefits segment offers traditional, voluntary, and consumer-directed health insurance products and related services, including medical, pharmacy, dental and behavioral health plans, Medicare Advantage and Medicare Supplement plans, PDPS and Medicaid health care management services.
It serves employer groups, individuals, college students, part-time and hourly workers, health plans, health care providers, governmental units, government-sponsored plans, labor groups, and expatriates.
CVS Health Corporation was founded in 1963 and is headquartered in Woonsocket, Rhode Island. The company was formerly known as CVS Caremark Corporation and changed its name to CVS Health Corporation in September 2014.
Headquartered in Woonsocket, Rhode Island, CVS Health Corporation operates across multiple segments to deliver health solutions in the United States.
CVS Health Corporation, ticker CVS, is currently priced at $93.26 and has a market capitalization of $118.99B. It ranks 131.
It operates in the Healthcare category and provides a range of health solutions through its three segments: Health Care Benefits, Health Services, and Pharmacy & Consumer Wellness.
The long‑term forecast shows upside potential, with a 2026 average price of $93.26, a 2030 average of $184.90, and a 2050 average of $1,095.49, indicating substantial upside over the multi‑year horizon.
A major floor 29.1% below — a decisive break under it would weaken the trend.
The nearest floor, 18.6% below — buyers have tended to step in here.
The nearest ceiling, 6.6% above — a clean break opens room to run.
A major ceiling 21.1% above — clearing it would confirm fresh momentum.
Key CVS support and resistance from recent price action — levels where the trend has historically paused or reversed. Percentages are the distance from the current price.
A snapshot of CVS market posture derived from its technical indicators and recent volatility. Higher trend and alignment lean bullish; higher risk means larger swings.
Technical Analysis
Indicators computed on daily closing prices.
| Period | SMA | Action | EMA | Action |
|---|---|---|---|---|
| MA 5 | $92.53 | Sell | $92.53 | Sell |
| MA 10 | $94.40 | Sell | $92.50 | Sell |
| MA 20 | $90.41 | Buy | $90.11 | Buy |
| MA 50 | $81.29 | Buy | $84.65 | Buy |
| MA 100 | $79.73 | Buy | $81.21 | Buy |
| MA 200 | $78.12 | Buy | $77.53 | Buy |
| Name | Value | Action |
|---|---|---|
| RSI (14) | 59.97 | Neutral |
| Stoch RSI (14) | 11.77 | Buy |
| CCI (20) | 23.80 | Neutral |
| Williams %R (14) | -56.19 | Info |
| MACD (12,26,9) | -0.57 | Sell |
| ROC (12) | 1.68 | Buy |
| Bollinger %B (20,2) | 0.58 | Neutral |
| Stochastic %K (14) | 43.81 | Neutral |
| TRIX (15) | 0.75 | Buy |
| Awesome (5,34) | 7.31 | Buy |
| Ultimate (7,14,28) | 40.18 | Neutral |
| Momentum (10) | -3.08 | Sell |
| Aroon Osc (25) | 60.00 | Buy |
| Hull MA (9) | 91.21 | Buy |
| ADX (14) | 31.81 | Buy |
| ATR (14) | 1.42 | Info |
The 30‑day technical picture is bullish, with positive momentum suggested by the RSI of 70. The SMA50 sits at $80.67 and the SMA200 at $77.86, indicating near‑term strength.
| Year | Min | Avg | Max | ROI | Sentiment |
|---|---|---|---|---|---|
| $70.08 | $92.07 | $124.82 | 0% | Neutral | |
| $104.35 | $127.73 | $163.66 | +39% | Bullish | |
| $112.79 | $140.59 | $184.84 | +53% | Bullish | |
| $121.44 | $153.67 | $206.24 | +67% | Bullish | |
| $138.93 | $178.13 | $243.30 | +93% | Bullish | |
| $152.80 | $198.28 | $275.05 | +115% | Bullish | |
| $181.82 | $238.58 | $335.60 | +159% | Bullish | |
| $212.55 | $281.82 | $401.50 | +206% | Bullish | |
| $231.83 | $310.42 | $447.49 | +237% | Bullish | |
| $254.03 | $343.35 | $500.42 | +273% | Bullish | |
| $403.05 | $568.10 | $867.43 | +517% | Bullish | |
| $681.16 | $1,029.51 | $1,684.56 | +10.2x | Bullish |
Current year — the forecast is anchored to the live price, so ROI shows 0%.
| Month | Min | Avg | Max | Change |
|---|---|---|---|---|
| May 2026 | $70.08 | $92.07 | $108.05 | +0.00% |
| June 2026 | $82.10 | $95.77 | $113.89 | +4.02% |
| July 2026 | $83.11 | $97.51 | $117.05 | +1.81% |
| August 2026 | $81.87 | $96.49 | $116.67 | -1.05% |
| September 2026 | $82.37 | $97.44 | $118.52 | +0.99% |
| October 2026 | $84.47 | $100.27 | $122.62 | +2.90% |
| November 2026 | $84.65 | $100.78 | $123.83 | +0.51% |
| December 2026 | $84.71 | $101.14 | $124.82 | +0.36% |
Click any year to see its month-by-month CVS forecast. Min / Avg / Max are a bear / base / bull scenario; ROI is the projected move from the current price. Change is the month-over-month move in the average. Estimates, not guarantees.
In 2026, CVS is projected to trade between $70.08 and $124.82, averaging $92.07 — a potential gain of 0% from today's $92.07. A consolidation phase looks the most probable path here.
CVS Health Corporation's 2027 outlook centres on $127.73, within a $104.35 to $163.66 range. That is up +39% on the projected 2026 average. That marks a +39% change versus current levels. Momentum favours further upside here.
By 2028, CVS could reach as high as $184.84, with a base case around $140.59 and support toward $112.79 — roughly +53% from $92.07. Buyers look set to stay in control over this stretch.
Expect CVS to range from $121.44 to $206.24 through 2029. The $153.67 average target implies a +67% move from current prices. That is up +9% on the projected 2028 average. Momentum favours further upside here.
The CVS price prediction for 2030 points to an average of $178.13 (low $138.93, high $243.30) — a potential gain of +93% on today's $92.07. Buyers look set to stay in control over this stretch.
In 2031, CVS is projected to trade between $152.80 and $275.05, averaging $198.28 — a potential gain of +115% from today's $92.07. That is up +11% on the projected 2030 average. Momentum favours further upside here.
CVS Health Corporation's 2032 outlook centres on $238.58, within a $181.82 to $335.60 range. That is up +20% on the projected 2031 average. That marks a +159% change versus current levels. Buyers look set to stay in control over this stretch.
By 2033, CVS could reach as high as $401.50, with a base case around $281.82 and support toward $212.55 — roughly +206% from $92.07. Momentum favours further upside here.
Expect CVS to range from $231.83 to $447.49 through 2034. The $310.42 average target implies a +237% move from current prices. That is up +10% on the projected 2033 average. Buyers look set to stay in control over this stretch.
The CVS price prediction for 2035 points to an average of $343.35 (low $254.03, high $500.42) — a potential gain of +273% on today's $92.07. Momentum favours further upside here.
In 2040, CVS is projected to trade between $403.05 and $867.43, averaging $568.10 — a potential gain of +517% from today's $92.07. That is up +65% on the projected 2035 average. Buyers look set to stay in control over this stretch.
CVS Health Corporation's 2050 outlook centres on $1,029.51, within a $681.16 to $1,684.56 range. That is up +81% on the projected 2040 average. That marks a +10.2x change versus current levels. Momentum favours further upside here.
Investing $1,000 in CVS today (≈ 10.861301 CVS) could be worth
$11,181.84
+$10,181.84 (+1018%) by 2050 · US Dollar
Based on the average projected CVS price of $1,029.51 in 2050.
Based on the base (average) forecast scenario. FX rates are indicative. Estimates only — not financial advice.
See what a past investment in CVSwould be worth at today's price.
$1,000 invested in CVS on May 27, 2025 (≈ 16.302576 CVS) would be worth
$1,500.98
+$500.98 (+50.1%) today · 1.50× · US Dollar
Based on a CVS entry price of $61.34 vs. today's $92.07.
| Invested | Entry price | Value today | Return |
|---|---|---|---|
| 1 week ago | $93.28 | $987.03 | -1.3% |
| 1 month ago | $78.36 | $1,174.96 | +17.5% |
| 3 months ago | $78.01 | $1,180.23 | +18.0% |
| 6 months ago | $80.36 | $1,145.72 | +14.6% |
| 1 year ago | $61.34 | $1,500.98 | +50.1% |
| All time (5.0y) ago | $85.87 | $1,072.2 | +7.2% |
Past performance from historical market data — it does not predict future results. FX rates are indicative. Not financial advice.
Enter a price to see how it sits against our CVS forecast.
Our base-case forecast reaches $180.00 around 2031.
Implied market cap at $180.00: $229.67B
The multi‑year forecast points to persistent upside with bullish sentiment in the later years. The 2030 average is $184.90, with a min of $144.18 and max of $252.60, and a return on investment of 98.3%. The 2040 forecast shows an average of $596.62 with a 539.7% ROI, and the 2050 forecast shows an average of $1,095.49 with a 1074.7% ROI.
These figures illustrate strong long‑term upside potential, though they are estimates, not guarantees, and carry inherent uncertainty.
Tap a question to reveal the answer.
The 2030 forecast shows an average price of $184.90, with a range from $144.18 to $252.60. The forecasted ROI is 98.3% and the sentiment is BULLISH.
Forecasts indicate bullish sentiment across multiple years and high long‑term ROI (2030: 98.3%, 2040: 539.7%, 2050: 1074.7%), but these are estimates and not guarantees.
Yes—the 2030 forecast shows min $144.18, max $252.60, and avg $184.90, which includes $150 within the expected range.
Current price $93.26 and market cap $118.99B.
The 2050 forecast shows an average price of $1,095.49 with a min of $724.75 and a max of $1,792.66, and a long‑run ROI of 1074.7%; sentiment is BULLISH.
CVS Health Corporation Community Discussion
0Share your CVS Health Corporation price prediction and read what the community thinks. Be respectful — comments are public and not financial advice.
Be the first to share your prediction…
What's your take? Add a comment above to start the conversation.